Evidence map›Paper›PMID 36278478›Full record

ArticlePain practice : the official journal of World Institute of Pain2023

Second-degree burn induced by high-concentration topical capsaicin with mobility sequelae: A case report.

Kilian Trin, Justine Perino, Marion Allouchery, Hélène Géniaux, Ghada Miremont, Francesco Salvo

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Pain practice : the official journal of World Institute of Pain, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Second-degree burn induced by high-concentration topical capsaicin with mobility sequelae: A case report.Pain practice : the official journal of World Institute of Pain · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Kilian TrinService de Pharmacologie Médicale, Centre Régional de Pharmacovigilance de Bordeaux, CHU de Bordeaux, Bordeaux, France.ORCID 0000-0002-7650-645X
Justine PerinoService de Pharmacologie Médicale, Centre Régional de Pharmacovigilance de Bordeaux, CHU de Bordeaux, Bordeaux, France.
Marion AlloucheryInserm, Bordeaux Population Health Research Center, Team Pharmacoepidemiology, UMR 1219, Univ. Bordeaux, Bordeaux Cedex, France.
Hélène GéniauxService de Pharmacologie, Toxicologie et Pharmacovigilance, CHU de Limoges, Limoges, France.
Ghada MiremontService de Pharmacologie Médicale, Centre Régional de Pharmacovigilance de Bordeaux, CHU de Bordeaux, Bordeaux, France.
Francesco SalvoService de Pharmacologie Médicale, Centre Régional de Pharmacovigilance de Bordeaux, CHU de Bordeaux, Bordeaux, France.ORCID 0000-0003-3210-7171
Université de Bordeaux · FRCentre Hospitalier Universitaire de Bordeaux · FRCentre Hospitalier Universitaire de Limoges · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-concentration topical capsaicin is used as a second-line treatment for neuropathic pain. Transient, mild burning sensation and erythema are expected adverse drug reactions. Here, we report the first case of second degree burn after the application of a high-concentration topical capsaicin patch with secondary mobility sequelae. Nine months after the application, neuropathic pain still remained and the patient described mobility difficulties in daily activities, preventing her from returning to work. This report aims to raise the question of the benefit/risk ratio of high concentration topical capsaicin.

Indexed as

BurnsNeuralgiaAdministration, TopicalCapsaicinFemaleHumansCapsaicinadverse drug reactioncapsaicinneuropathic painpharmacovigilancesequelae

Identifiers

PMID36278478
PMCPMC10099465
OpenAlexW4307181077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.